Research Article
Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
Table 2
Patient and tumor characteristics.
| | All patients (n = 270) |
| | Age (years) | | | Mean (SD) | 56.9 (13.8) | | n (%) | | stage | | | Stage I | 67 (24.9) | | Stage II | 26 (9.7) | | Stage III | 144 (53.5) | | Stage IV | 32 (11.9) | | Missing | 1 |
| | Tumor type | | | Serous | 147 (59.8) | | Mucinous | 37 (15.0) | | Endometrioid | 42 (17.1) | | Clear cell | 17 (6.9) | | Undifferentiated | 3 (1.2) | | Missing | 24 |
| | Differentiation grade | | | Grade I | 51 (20.2) | | Grade II | 77 (30.6) | | Grade III | 113 (44.8) | | Undifferentiated | 11 (4.4) | | Missing | 18 |
| | Residual disease | | | 2 cm | 155 (59.0) | | 2 cm | 94 (35.7) | | 21 (5.3) |
|
|
FIGO: International Federation of Gynecology and Obstetrics. Amount unknown.
|
